Tag Archives: j

Top 5 Clean Energy Stocks To Buy Right Now

HDFC Securities’s research report on Tech Mahindra

Tech Mahindra delivered poor revenue growth in 1QFY19 while margin performance was better than expected. Revenue stood at USD 1,224mn (-1.6% QoQ, +0.3% CC), vs our estimate of USD 1,228mn. Enterprise (+1.8%, +3.8% CC QoQ) continue to drive growth led by traction in Manufacturing (+2.5% QoQ) and BFSI (+2.9%). Digital (27% of rev, +30% YoY) is growing in-line with industry average and is driving enterprise growth. Telecom (39.6% of rev, -6.3% QoQ) is dragging overall revenue growth; however management sees it as a seasonal blip and expect recovery form 2QFY19E based on deal wins at the end of the quarter. Deal TCV stands at USD 260mn, out of which ~50% is Telecom.

Outlook

Weve factored USD revenue growth of 7.6/10.6% for FY19/20E, implying revenue CQGR of 3.2/2.2% for FY19/20E and factored EBITDA% at 16.7/17.1%. Maintain BUY with a TP of Rs 740 based on 15x FY20E EPS.

For all recommendations report,click here

Top 5 Clean Energy Stocks To Buy Right Now: Xcerra Corporation(XCRA)

Xcerra Corporation (Xcerra or the Company), formerly known as LTX-Credence Corporation, is a global provider of test and handling capital equipment, interface products, test fixtures and related services to the semiconductor and electronics manufacturing industries. We design, manufacture and market products and services that address the broad, divergent requirements of the mobility, industrial, medical, automotive and consumer end markets, offering a comprehensive portfolio of solutions and technologies, and a global network of strategically deployed applications and support resources. We operate in the semiconductor and electronics manufacturing test markets through our atg-Luther & Maelzer, Everett Charles Technologies (ECT), LTX-Credence and Multitest businesses.   Advisors’ Opinion:

  • [By Garrett Baldwin]

    Get an exclusive invitation to meet Tim before everyone else right here.

    Three Stocks to Watch Today: LC, GE, GS
    General Electric Co. (NYSE: GE) has ousted its CEO John Flannery. Shares are up more than 10% as investors celebrated the news. GE has been mired in a slump, particularly its turbine business. The firm’s new CEO is H. Lawrence Culp, Jr., the former CEO of the industrial firm Danaher. Shares of LendingClub Corp.(NYSE: LC) are under pressure after the SEC charged one of the firm’s divisions with mishandling client money. This weekend, the firm reached a settlement with regulators on charges that the firm inflated its revenue and made changes to products to make the firm look healthier than it is. As a result, the firm’s board of directors forced CEO Renaud Laplanche to resign. Goldman Sachs Group Inc.(NYSE: GS) has replaced CEO Lloyd Blankfein, who has stepped down after more than a decade at the helm at one of Wall Street’s most iconic banks. David Solomon – who has previously served as the firm’s president and COO – will now bet the new CEO. His tenure begins at a tough time for Goldman as the bank struggles with lower trading desk revenues. Look for earnings reports today from Cal-Maine Foods Inc. (NASDAQ: CALM) and Xcerra Corp.(NASDAQ: XCRA).

    Follow Money MorningonFacebook, Twitter, and LinkedIn.

  • [By Rich Smith]

    “Robust industry trends” in the semiconductor industry, argues Davidson, give this “leading provider of semiconductor test handlers and … emerging player in the associated contactor and vision inspection markets” an “ample runway for growth.” Cohu’s also in the process of acquiring one of its top competitors, Xcerra Corporation (NASDAQ:XCRA), in a deal slated to close next quarter, which will add scale to Cohu’s business even as it removes a source of price competition.

  • [By Garrett Baldwin]

    The system that could make you $104,000 richer in the next 12 months…

    Darden Restaurants Inc.(NYSE: DRI) leads a fairly busy day of earnings reports. The restaurant management giant easily topped Wall Street profit numbers by reporting earnings per share of $1.34. The average Wall Street estimate was $1.23. The firm also easily topped revenue expectations. DRI shares were up 4.5% this morning. The problems continue to mount for General Electric Co. (NYSE: GE). This morning, JPMorgan Securities slashed its price target for the U.S. conglomerate from $11 to $10 per share. The investment firm cited ongoing challenges to the company’s turbine business. General Electric has been under pressure since the financial crisis, and it was the worst performing stock on the Dow in 2017 before it was ultimately replaced on the index. Shares of Under Armour Inc. (NYSE: UAA) added 3.4% this morning, but the driver wasn’t necessarily positive for the global apparel giant. According to reports, the Baltimore-based sports apparel giant is cutting 3% of its international workforce. That equates to roughly 400 jobs. The company did raise its fiscal 2018 earnings forecast, and issued a revised update of severance costs. Look for earnings reports from Micron Technology Inc. (NASDAQ: MU), Thor Industries Inc.(NYSE: THO), United Natural Foods Inc.(NASDAQ: UNFI), Steelcase Inc. (NYSE: SCS), Scholastic Corp.(NASDAQ: SCHL), and Xcerra Corp.(NASDAQ: XCRA).

    FollowMoney MorningonFacebook,Twitter, andLinkedIn.

Top 5 Clean Energy Stocks To Buy Right Now: TRACON Pharmaceuticals, Inc.(TCON)

TRACON Pharmaceuticals, Inc., incorporated on October 28, 2004, is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics for cancer, wet age-related macular degeneration (wet AMD) and fibrotic diseases. The Company’s research focuses on antibodies that bind to the endoglin receptor, which is essential to angiogenesis (the process of new blood vessel formation) and a contributor to fibrosis (tissue scarring). The Company’s lead product candidate, TRC105, is an endoglin antibody that is being developed for the treatment of multiple solid tumor types in combination with inhibitors of the vascular endothelial growth factor (VEGF) pathway. TRC205 is being developed for the treatment of fibrotic disease. The Company is also developing TRC102, a small molecule that is in clinical development for the treatment of lung cancer and glioblastoma.

TRC105

The Company is developing TRC105 for use in combination with agents that inhibit angiogenesis by targeting the VEGF pathway. VEGF is required for angiogenesis. TRC105 binds to the endoglin receptor at a precise location to inhibit endothelial cell activation and angiogenesis. TRC105 has been studied in over six completed Phase II clinical trials and approximately three completed Phase I clinical trials, and is being dosed in over five Phase II clinical trials. TRC105 is focused on approximately two orphan indications, gestational trophoblastic neoplasia (GTN) and angiosarcoma. The next tier of development includes ongoing Phase II trials in renal cell carcinoma, glioblastoma and hepatocellular carcinoma. The Company has produced formulations of TRC105 for development in ophthalmology, which are developed for the treatment of wet AMD, the cause of blindness in the Western world.

TRC205

The Company’s TRC205 is a humanized, deimmunized anti-endoglin antibody. TRC205 is being developed for the treatment of fibrotic diseases, including nonalcoholic ! steatohepatitis (NASH) and idiopathic pulmonary fibrosis (IPF).

TRC102

The Company is developing TRC102 (methoxyamine hydrochloride) to reverse resistance to specific chemotherapeutics by inhibiting base excision repair (BER). TRC102 interrupts BER by binding within apurinic/apyrimidinic (AP) sites, converting the AP site to a substrate for the enzyme topoisomerase II, which cleaves TRC102-bound deoxy ribonucleic acid (DNA), resulting in an accumulation of DNA strand breaks that trigger cellular apoptosis or programmed cell death. TRC102 is being developed to reverse resistance to Temodar, an alkylating chemotherapeutic, as well as to Alimta and Fludara, two antimetabolite chemotherapeutics. TRC102 began Phase II development through a Phase II clinical trial that combines TRC102 in patients with mesothelioma, as well as a Phase II clinical trial of TRC102 in patients with glioblastoma.

The Company competes with Pfizer, Inc., Acceleron Pharma Inc., Amgen, Inc., MedImmune LLC, OncoMed Pharmaceuticals Inc., Regeneron Pharmaceuticals, Inc., Roche AG, Genfit Corp., Intercept Pharmaceuticals, Inc., Conatus Pharmaceuticals Inc., Galmed Medical Research Ltd., Gilead Sciences, Inc., Immuron Ltd., Shire plc, Mochida Pharmaceutical Co., Ltd., NasVax Ltd., Raptor Pharmaceutical Corp., Takeda Pharmaceutical Company Limited, InterMune, Inc., Boehringer Ingelheim, Biogen Idec., Bristol-Myers Squibb, Celgene Corporation, Fibrogen, Inc., Gilead, Janssen Pharmaceuticals Inc., Novartis AG, Sanofi S.A, Tesaro, Inc. and AbbVie Inc.

Advisors’ Opinion:

  • [By Stephan Byrd]

    TRACON Pharmaceuticals Inc (NASDAQ:TCON) fell 12.3% during trading on Wednesday . The company traded as low as $1.23 and last traded at $1.21. 896,880 shares changed hands during trading, an increase of 112% from the average session volume of 422,831 shares. The stock had previously closed at $1.38.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on TRACON Pharmaceuticals (TCON)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Clean Energy Stocks To Buy Right Now: Equity Commonwealth(EQC)

Equity Commonwealth (EQC), incorporated on October 9, 1986, is an internally managed and self-advised real estate investment trust (REIT). The Company is engaged in the ownership and operation primarily of office buildings in central business district (CBD) and suburban locations throughout the United States. The Company’s two reportable segments include CBD properties and suburban properties. As of December 31, 2014, its portfolio included 156 properties (262 buildings) with a combined 42.9 million square feet. The Company’s portfolio consisted of 40 properties (53 buildings) with a combined 21.9 million square feet located in CBD locations and 116 properties (209 buildings) with a combined 21.0 million square feet located in suburban locations. Eleven of its properties (11 buildings) with a combined 1.8 million square feet are located in Australia.

As on December 31, 2014, the Company had real estate investments in 156 properties (262 buildings) that were leased to approximately 1,800 tenants and 85.8% of the Company’s total square feet were leased. The Company’s principal source of funds for its operations is rents from tenants at its properties. Its tenants include Office Depot, Inc., Expedia, Inc., John Wiley & Sons, Inc, Telstra Corporation Limited, PNC Financial Services Group, United States Government, Royal Dutch Shell plc, J.P. Morgan Chase & Co., Flextronics International Ltd., United Healthcare Services Inc., The Bank of New York Mellon Corp., Carmike Cinemas, Inc., Bankers Life and Casualty Company, Jones Day, Wells Fargo & Co, Level 3 Communications, Inc., Towers Watson & Co, Ballard Spahr LLP and RE/MAX Holdings, Inc.

Advisors’ Opinion:

  • [By Tim Melvin]

    Zell is the Chairman of Equity Commonwealth (NYSE: EQC), an office REIT that he and some activist investors took over back in 2014.

    His management team has spent the last five years selling what they consider to be non-core properties.

  • [By Shane Hupp]

    Ffcm LLC increased its position in Equity Commonwealth (NYSE:EQC) by 97.5% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 39,928 shares of the real estate investment trust’s stock after acquiring an additional 19,711 shares during the quarter. Ffcm LLC’s holdings in Equity Commonwealth were worth $1,198,000 at the end of the most recent quarter.

  • [By Matthew DiLallo]

    Equity Commonwealth (NYSE:EQC) continued the steady pare-down of its property portfolio during the fourth quarter, ending the year with only 10 remaining real estate assets. However, for the first time in years, the company’s funds from operations increased as it was able to more than offset the lost income with gains elsewhere. But it’s not yet clear whether the company’s earnings growth will continue, since it has several more property sales in the works, which could weigh on its results until it starts making acquisitions.

Top 5 Clean Energy Stocks To Buy Right Now: Fisher(j)

James Fisher and Sons plc, together with its subsidiaries, provides marine services and specialist engineering services in the United Kingdom, Ireland, Norway, and internationally. The company operates through four segments: Specialist Technical Services, Offshore Oil Services, Defence, and Marine Oil. The Specialist Technical Services engages in the hire and sale of large scale pneumatic fenders; provision of ship to ship transfer services; and design and supply of systems for monitoring strains and stress in structures and equipment. This segment also offers non-destructive testing services; and design, engineering, and manufacturing services for the nuclear decommissioning industries. The Offshore Oil Services segment manufactures and rents equipment for the offshore oil and gas industry; and designs and manufactures specialist down hole tools and equipment for extracting oil. This segment also offers related specialist labor, such as cranes, winches and pumps to the of fshore sector, wind farms, and for subsea operations. The Defence segment designs, constructs, and operates submarine rescue vehicles and remotely operated vehicles; and operates surface ships. It offers marine services to the Ministry of Defence (MoD) and other navies, including the United Kingdom; maintenance, asset management, and consultancy services; military strategic sealift capability through its operation of six roll on ? roll off vessels for the MoD; and submarine rescue services to the government of Singapore. The Marine Oil segment is involved in the sea transportation of clean petroleum products in north west Europe; and wharf operations. The company was founded in 1847 and is headquartered in Barrow-in-Furness, the United Kingdom.

Advisors’ Opinion:

  • [By Logan Wallace]

    Joincoin (CURRENCY:J) traded 22.3% higher against the dollar during the 1 day period ending at 9:00 AM E.T. on October 2nd. Joincoin has a total market capitalization of $95,205.00 and $22.00 worth of Joincoin was traded on exchanges in the last 24 hours. During the last seven days, Joincoin has traded 6.1% lower against the dollar. One Joincoin coin can now be bought for approximately $0.0299 or 0.00000456 BTC on major cryptocurrency exchanges.

  • [By Logan Wallace]

    Joincoin (CURRENCY:J) traded 12.5% higher against the dollar during the 24-hour period ending at 10:00 AM ET on September 30th. Joincoin has a market cap of $98,508.00 and $17.00 worth of Joincoin was traded on exchanges in the last day. One Joincoin coin can now be bought for $0.0309 or 0.00000467 BTC on popular exchanges. During the last seven days, Joincoin has traded 8.2% lower against the dollar.

  • [By Shane Hupp]

    Joincoin (J) is a proof-of-work (PoW) coin that uses the Multiple hashing algorithm. Its launch date was August 13th, 2014. Joincoin’s total supply is 3,173,702 coins. Joincoin’s official website is bitcointalk.org/index.php?topic=737405.0. Joincoin’s official Twitter account is @Joincoin_Team.

  • [By Joseph Griffin]

    Joincoin (CURRENCY:J) traded 1.7% lower against the U.S. dollar during the 24 hour period ending at 0:00 AM ET on May 8th. Joincoin has a total market cap of $145,714.00 and $7.00 worth of Joincoin was traded on exchanges in the last 24 hours. During the last week, Joincoin has traded up 28.6% against the U.S. dollar. One Joincoin coin can currently be bought for about $0.0471 or 0.00000521 BTC on cryptocurrency exchanges.

Top 5 Clean Energy Stocks To Buy Right Now: Marathon Oil Corporation(MRO)

Marathon Oil Corporation, through its subsidiaries, operates as an international energy company with operations in the United States, Canada, Africa, the Middle East, and Europe. It operates through three segments: Exploration and Production, Oil Sands Mining, and Integrated Gas. The Exploration and Production segment explores for, produces, and markets liquid hydrocarbons and natural gas. The Oil Sands Mining segment mines, extracts, and transports bitumen from oil sands deposits in Alberta, Canada; and upgrades the bitumen to produce and market synthetic crude oil and vacuum gas oil. The Integrated Gas segment markets and transports products manufactured from natural gas, such as liquified natural gas and methanol. The company was formerly known as USX Corporation and changed its name to Marathon Oil Corporation in July 2001. Marathon Oil Corporation was founded in 1887 and is based in Houston, Texas.

Advisors’ Opinion:

  • [By Matthew DiLallo]

    Marathon Oil (NYSE:MRO) based its 2019 plans on oil averaging $50 a barrel. At that price point, the company can fund its $2.6 billion capital spending plan — enough money to grow its U.S. oil production by 12% this year — and its dividend with plenty of room to spare. Marathon has so much breathing room that it can fund its 2019 budget as well as its dividend at $45 oil, which means it’s on track to produce a gusher of free cash now that oil is in the mid-$50s. Marathon currently expects to return the bulk of that money to shareholders through additional share repurchases, which sets up investors to potentially earn some high-octane total returns this year if oil keeps going higher.

  • [By Matthew DiLallo]

    Marathon Oil (NYSE:MRO) delivered exceptional operational and financial results in 2018. Not only did its U.S. oil production outperformthe midpoint of its initial guidance range by 22.5%, but it also generated a boatload of free cash flow. That strong performance is one of many reasons Marathon CEO Lee Tillman believes his company checks all the boxes for investors. He laid out the case for the company on itsfourth-quarter conference call, detailing four reasons Marathon is an ideal oil stock. Here’s what he said.

Top 10 Heal Care Stocks To Buy Right Now

Deutsche Bank set a €5.30 ($6.16) target price on Enel (BIT:ENEL) in a research report sent to investors on Thursday morning. The brokerage currently has a neutral rating on the stock.

ENEL has been the subject of a number of other research reports. Societe Generale set a €6.00 ($6.98) target price on shares of Enel and gave the stock a buy rating in a research report on Wednesday, May 23rd. Deutsche Bank set a €5.40 ($6.28) target price on shares of Enel and gave the stock a neutral rating in a research report on Thursday, May 31st. Goldman Sachs Group set a €6.15 ($7.15) target price on shares of Enel and gave the stock a buy rating in a research report on Wednesday, May 2nd. Morgan Stanley set a €6.00 ($6.98) target price on shares of Enel and gave the stock a buy rating in a research report on Tuesday, May 29th. Finally, Royal Bank of Canada set a €5.75 ($6.69) target price on shares of Enel and gave the stock a buy rating in a research report on Thursday, May 31st. Five investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. The company currently has a consensus rating of Buy and an average target price of €5.76 ($6.69).

Top 10 Heal Care Stocks To Buy Right Now: Seadrill Limited(SDRL)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    Shares of Seadrill (NYSE:SDRL) rocketed in May, ending the month up 78%. Fueling the offshore driller’s rebound were fading investor fears after the company received approval for its plan to exit bankruptcy in April.

  • [By Lisa Levin]

    Thursday morning, the energy shares rose 0.76 percent. Meanwhile, top gainers in the sector included Seadrill Limited (NYSE: SDRL), up 59 percent, and EP Energy Corporation (NYSE: EPE) up 7 percent.

  • [By Lisa Levin]

    Thursday afternoon, the energy shares rose 1.16 percent. Meanwhile, top gainers in the sector included Seadrill Limited (NYSE: SDRL), up 33 percent, and Ultra Petroleum Corp. (NYSE: UPL) up 14 percent.

  • [By Lisa Levin]

    On Wednesday, the energy shares climbed 1.48 percent. Meanwhile, top gainers in the sector included SeaDrill Limited (NYSE: SDRL), up 15 percent, and EP Energy Corporation (NYSE: EPE), up 15 percent.

  • [By Money Morning News Team]

    (Nasdaq: CNET)

    $2.95 34.76%
    Seadrill Ltd. (NYSE: SDRL) $0.28 33.81%
    Intelsat Corp. (NYSE: I) $9.11 31.50%
    Navios Maritime Midstream Partners LP (NYE: NAP) $4.42 29.18%
    Limelight Networks Inc. (Nasdaq: LLNW) $4.89 28.61%
    Enphase Energy Inc. (Nasdaq: ENPH) $5.05 24.62%

    As you can see in the table above, penny stocks have the potential to provide tremendous returns for enterprising investors. However, it’s important to note that investing in penny stocks is also incredibly risky.

  • [By Lisa Levin]

    Wednesday morning, the energy shares climbed 1.29 percent. Meanwhile, top gainers in the sector included SeaDrill Limited (NYSE: SDRL), up 19 percent, and Energy XXI Gulf Coast, Inc. (NASDAQ: EGC), up 10 percent.

Top 10 Heal Care Stocks To Buy Right Now: AMTEK, Inc.(AME)

Advisors’ Opinion:

  • [By Logan Wallace]

    These are some of the news articles that may have impacted Accern Sentiment’s scoring:

    Get AMETEK alerts:

    Ac Power Source Supply Market 2018 Global Share- AMETEK Programmable Power, Pacific Power Source and … (theexpertconsulting.com) The Whispers about AMETEK, Inc. (AME) and Omeros Corporation (OMER) (nmsunews.com) Global Neutron Generators Market Analysis 2018 Del Mar Photonics, VNIIA, AMETEK ORTEC, Adelphi Technology … (theexpertconsulting.com) AMETEK, Inc. (AME): Most Popular stock: (stockquote.review) Ametek granted partial judgment in alleged ground contamination cased filed by mobile home parks’ owners (norcalrecord.com)

    Several research firms have recently commented on AME. Morgan Stanley lifted their price target on shares of AMETEK from $76.00 to $79.00 and gave the company an “equal weight” rating in a research report on Thursday, May 3rd. BMO Capital Markets lifted their price target on shares of AMETEK from $90.00 to $92.00 and gave the company an “outperform” rating in a research report on Thursday, May 3rd. Zacks Investment Research lowered shares of AMETEK from a “buy” rating to a “hold” rating in a research report on Thursday, April 12th. DA Davidson began coverage on shares of AMETEK in a research report on Thursday, April 12th. They set a “buy” rating and a $85.00 price target on the stock. Finally, ValuEngine raised shares of AMETEK from a “hold” rating to a “buy” rating in a research report on Thursday, March 1st. Three investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus price target of $82.00.

  • [By Ethan Ryder]

    UBS Group AG boosted its holdings in AMETEK, Inc. (NYSE:AME) by 97.1% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 260,024 shares of the technology company’s stock after acquiring an additional 128,083 shares during the period. UBS Group AG owned about 0.11% of AMETEK worth $19,754,000 at the end of the most recent quarter.

  • [By Shane Hupp]

    Mountain Pacific Investment Advisers Inc. ID trimmed its stake in shares of AMETEK, Inc. (NYSE:AME) by 1.1% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 533,274 shares of the technology company’s stock after selling 5,917 shares during the quarter. AMETEK accounts for 4.2% of Mountain Pacific Investment Advisers Inc. ID’s portfolio, making the stock its 3rd largest holding. Mountain Pacific Investment Advisers Inc. ID’s holdings in AMETEK were worth $40,513,000 as of its most recent SEC filing.

  • [By Motley Fool Transcribing]

    Ametek (NYSE:AME) Q4 2018 Earnings Conference CallFeb. 5, 2019 8:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Ethan Ryder]

    Rhumbline Advisers grew its holdings in shares of AMETEK, Inc. (NYSE:AME) by 3.0% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 450,212 shares of the technology company’s stock after purchasing an additional 13,189 shares during the quarter. Rhumbline Advisers’ holdings in AMETEK were worth $32,487,000 at the end of the most recent reporting period.

  • [By Joseph Griffin]

    AMETEK (NYSE:AME) had its target price upped by BMO Capital Markets from $92.00 to $93.00 in a report issued on Wednesday morning. BMO Capital Markets currently has an outperform rating on the technology company’s stock.

Top 10 Heal Care Stocks To Buy Right Now: Fisher(j)

Advisors’ Opinion:

  • [By Shane Hupp]

    Joincoin (CURRENCY:J) traded 17.5% lower against the U.S. dollar during the twenty-four hour period ending at 17:00 PM ET on June 2nd. Over the last seven days, Joincoin has traded down 4.4% against the U.S. dollar. One Joincoin coin can now be purchased for $0.0862 or 0.00001129 BTC on major exchanges. Joincoin has a market capitalization of $267,889.00 and approximately $123.00 worth of Joincoin was traded on exchanges in the last 24 hours.

  • [By Joseph Griffin]

    Joincoin (CURRENCY:J) traded 1.7% lower against the U.S. dollar during the 24 hour period ending at 0:00 AM ET on May 8th. Joincoin has a total market cap of $145,714.00 and $7.00 worth of Joincoin was traded on exchanges in the last 24 hours. During the last week, Joincoin has traded up 28.6% against the U.S. dollar. One Joincoin coin can currently be bought for about $0.0471 or 0.00000521 BTC on cryptocurrency exchanges.

  • [By Logan Wallace]

    Joincoin (CURRENCY:J) traded 12.5% higher against the dollar during the 24-hour period ending at 10:00 AM ET on September 30th. Joincoin has a market cap of $98,508.00 and $17.00 worth of Joincoin was traded on exchanges in the last day. One Joincoin coin can now be bought for $0.0309 or 0.00000467 BTC on popular exchanges. During the last seven days, Joincoin has traded 8.2% lower against the dollar.

  • [By Shane Hupp]

    Joincoin (J) is a proof-of-work (PoW) coin that uses the Multiple hashing algorithm. Its launch date was August 13th, 2014. Joincoin’s total supply is 3,173,702 coins. Joincoin’s official website is bitcointalk.org/index.php?topic=737405.0. Joincoin’s official Twitter account is @Joincoin_Team.

  • [By Logan Wallace]

    Joincoin (CURRENCY:J) traded 22.3% higher against the dollar during the 1 day period ending at 9:00 AM E.T. on October 2nd. Joincoin has a total market capitalization of $95,205.00 and $22.00 worth of Joincoin was traded on exchanges in the last 24 hours. During the last seven days, Joincoin has traded 6.1% lower against the dollar. One Joincoin coin can now be bought for approximately $0.0299 or 0.00000456 BTC on major cryptocurrency exchanges.

Top 10 Heal Care Stocks To Buy Right Now: AmerisourceBergen Corporation (Holding Co)(ABC)

Advisors’ Opinion:

  • [By Logan Wallace]

    AmerisourceBergen (NYSE: ABC) and Trxade Group (OTCMKTS:TRXD) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, dividends, earnings, institutional ownership and profitability.

  • [By Logan Wallace]

    These are some of the news stories that may have impacted Accern Sentiment Analysis’s analysis:

    Get AmerisourceBergen alerts:

    Stocks that Will Always Try to Do the Right Things: AmerisourceBergen Corporation (ABC), Republic Services, Inc. (RSG) (nmsunews.com) Fortune’s 5 most influential pharmaceutical distributors and PBMs (beckershospitalreview.com) Analyzing CVS Health and Walgreens’ Acquisitions (finance.yahoo.com) US Bioservices Collaborates with MedImpact Direct to Support Hemophilia Patients (businesswire.com) Add Bucks County to list of those suing opioid manufacturers, distributors (finance.yahoo.com)

    NYSE ABC opened at $82.14 on Friday. AmerisourceBergen has a fifty-two week low of $71.90 and a fifty-two week high of $106.27. The company has a debt-to-equity ratio of 1.38, a quick ratio of 0.48 and a current ratio of 0.94. The stock has a market cap of $18.15 billion, a price-to-earnings ratio of 13.97, a P/E/G ratio of 1.25 and a beta of 1.04.

  • [By Lee Jackson]

    Recently the managers removed AmerisourceBergen Corp (NYSE: ABC) and used the proceeds from the sale to increase the position they already held in Unitedhealth Group Inc. (NYSE: UNH).

  • [By Shane Hupp]

    AmerisourceBergen Corp. (NYSE:ABC) insider Robert P. Mauch sold 1,000 shares of the business’s stock in a transaction that occurred on Wednesday, June 13th. The shares were sold at an average price of $90.00, for a total value of $90,000.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

  • [By Shane Hupp]

    Dupont Capital Management Corp lessened its stake in shares of AmerisourceBergen (NYSE:ABC) by 92.7% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,327 shares of the company’s stock after selling 16,975 shares during the quarter. Dupont Capital Management Corp’s holdings in AmerisourceBergen were worth $114,000 as of its most recent filing with the Securities and Exchange Commission.

Top 10 Heal Care Stocks To Buy Right Now: Open Text Corporation(OTEX)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Open Text (OTEX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Open Text (OTEX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Open Text Corp (TSE:OTEX) (NASDAQ:OTEX)’s share price hit a new 52-week high during trading on Monday . The stock traded as high as C$46.80 and last traded at C$46.53, with a volume of 121029 shares changing hands. The stock had previously closed at C$46.16.

Top 10 Heal Care Stocks To Buy Right Now: Daiichi Sankyo Company, Limited (DSKYF)

Advisors’ Opinion:

  • [By ]

    Daiichi Sankyo (OTCPK:DSKYF)

    There are 4 members of the EGF receptor family, but in cancer research we tend to focus mainly on the first two: EGFR and HER2. But we are also gaining a better understanding of the third family member, HER3, which is an odd duck because of its willingness to form dimers not with itself, but with other members of the EGFR family. And it is highly active in PI3K/Akt signaling, as well. So it’s no surprise that companies are trying to exploit this receptor as a therapeutic target. DSKYF’s U3-1402 is an antibody-drug conjugate targeting HER3 and delivering a lethal payload to tumor cells. This phase 1/2 study focused on the use of this agent in metastatic breast cancer overexpressing HER3.

Top 10 Heal Care Stocks To Buy Right Now: Fitbit, Inc.(FIT)

Advisors’ Opinion:

  • [By Chris Lange]

    Fitbit Inc. (NYSE: FIT) also is set to release its most recent quarterly results on Monday. The consensus forecast calls for a net loss of $0.01 per share and $589.1 million in revenue. Shares closed on Friday at $5.28. The consensus price target is $6.64, and the 52-week range is $4.90 to $7.32.

  • [By Stephan Byrd]

    Shares of Fitbit Inc (NYSE:FIT) gapped up prior to trading on Tuesday . The stock had previously closed at $6.11, but opened at $5.89. Fitbit shares last traded at $6.26, with a volume of 494885 shares traded.

  • [By Leo Sun]

    Facebook acquired the Moves fitness app in 2014. It seemed like a smart purchase at the time, since surging demand for Fitbit (NYSE:FIT) devices had sparked a land grab in the wearables market. Move tracked a user’s location, recorded different movements (like walking, running, and cycling) between locations, and logged the number of steps taken. The app had scored about 40 million downloads at the time of Facebook’s buyout.

  • [By Rich Duprey]

    Fitbit (NYSE:FIT) has shipped some 1 million Versa smartwatches in a little over a month’s time. That indicates it not only got its product right this time, but that it is finally also a worthy competitor to Apple (NASDAQ:AAPL).

  • [By Evan Niu, CFA]

    Apple (NASDAQ:AAPL) and Fitbit (NYSE:FIT) have emerged as the two clear market leaders in smartwatches, with Apple Watch leading the way but Fitbit’s growing portfolio of smartwatches helping it secure the No. 2 spot while simultaneously driving a turnaround for the smaller company. Meanwhile, Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL) subsidiary Google has ceded share, although the search giant is expected to jump in directly with a first-party Pixel Watch in the near future. Rumors of the company’s foray into the market were only fueled by recent news that Google acquired smartwatch tech from Fossil and is hiring for wearables design and engineering execs.

  • [By Motley Fool Staff]

    Gardner: Alright, company No. 5. Looking back over our first four, they’ve all been pretty good stock picks of ours, companies that a lot of Fools own and have done well with. This is one of my very worst picks, I’m sorry to say. Maybe a little bit of a hint, because it’s probably not that good a number or big a number these days. Matt, do you ever want a Fitbit (NYSE:FIT)?

Top 10 Heal Care Stocks To Buy Right Now: TherapeuticsMD, Inc.(TXMD)

Advisors’ Opinion:

  • [By Maxx Chatsko]

    Shares of TherapeuticsMD (NASDAQ:TXMD) rose more than 24% last month, according to data provided by S&P Global Market Intelligence. On the final day of July, the company announced the acquisition of a novel birth control product, Annovera, which then received U.S. Food and Drug Administration marketing approval in August.

  • [By Ethan Ryder]

    TherapeuticsMD Inc (NASDAQ:TXMD)’s share price was up 6.4% on Friday . The stock traded as high as $6.07 and last traded at $6.02. Approximately 2,747,655 shares were traded during mid-day trading, an increase of 38% from the average daily volume of 1,984,159 shares. The stock had previously closed at $5.66.

  • [By Brian Feroldi]

    After receiving some analyst love, shares of TherapeuticsMD (NASDAQ:TXMD), a commercial-stage biopharma focused on women’s health, rose 13% as of 3:35 p.m. EDT Tuesday.

  • [By Keith Speights]

    Axovant Sciences (NASDAQ:AXON), Deciphera Pharmaceuticals (NASDAQ:DCPH), and TherapeuticsMD (NASDAQ:TXMD) stocks soared by 26% or more this week. What sent these drug stocks into orbit? And are they still buys? Here’s the scoop behind the big gains and what could be next for the companies.

  • [By Cory Renauer]

    Shares of TherapeuticsMD (NASDAQ:TXMD), a biopharmaceutical company focused on women’s health, jumped 37.8% higher in January, according to data from S&P Global Market Intelligence. Investors were glad to hear the company’s new estradiol treatment for dyspareunia due to menopause is off to a better start than originally expected.

  • [By Joseph Griffin]

    JPMorgan Chase & Co. initiated coverage on shares of TherapeuticsMD (NASDAQ:TXMD) in a report issued on Friday, MarketBeat Ratings reports. The brokerage issued an overweight rating and a $11.00 price target on the stock.

Top 10 Heal Care Stocks To Buy Right Now: Golar LNG Partners LP(GMLP)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    Shares of oil producers Laredo Petroleum (NYSE:LPI) and SM Energy (NYSE:SM), as well as units of Golar LNG Partners LP (NASDAQ:GMLP), an MLP that owns liquified natural gas carriers and floating storage and regasification units, all declined by double digits by Friday afternoon. Lower oil prices weighed on the first two, while an analyst downgrade was the culprit in the latter.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Golar LNG Partners (GMLP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Motley Fool Staff]

    Golar LNG Partners Partnership (NASDAQ:GMLP) Q1 2018 Earnings Conference CallMay. 31, 2018 11:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Matthew DiLallo]

    Shares of Golar LNG Limited (NASDAQ:GLNG) are plunging today, down more than 17% as of 10:45 a.m. EDT, after the company reported lackluster first-quarter results. The company’s master limited partnership, Golar LNG Partners (NASDAQ:GMLP), also dropped, falling nearly 10% by midmorning.

  • [By Stephan Byrd]

    Media stories about Golar LNG Partners (NASDAQ:GMLP) have trended somewhat positive on Monday, according to Accern Sentiment. The research firm rates the sentiment of news coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Golar LNG Partners earned a media sentiment score of 0.23 on Accern’s scale. Accern also assigned media stories about the shipping company an impact score of 46.501475004652 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

Top 10 Heal Care Stocks To Buy Right Now: DCT Industrial Trust Inc(DCT)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Teza Capital Management LLC bought a new stake in DCT Industrial Trust Inc (NYSE:DCT) in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 6,379 shares of the real estate investment trust’s stock, valued at approximately $359,000.

  • [By Joseph Griffin]

    Shares of DCT Industrial Trust Inc (NYSE:DCT) have been given an average recommendation of “Hold” by the ten ratings firms that are presently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, eight have given a hold rating and one has assigned a buy rating to the company. The average 12-month target price among brokerages that have issued ratings on the stock in the last year is $62.83.

  • [By Logan Wallace]

    DECENT (CURRENCY:DCT) traded down 20.5% against the U.S. dollar during the 1-day period ending at 23:00 PM ET on September 5th. Over the last seven days, DECENT has traded 14% lower against the U.S. dollar. DECENT has a total market cap of $8.35 million and approximately $216,900.00 worth of DECENT was traded on exchanges in the last day. One DECENT coin can now be purchased for $0.16 or 0.00002516 BTC on major exchanges including Bittrex, Upbit, BCEX and HitBTC.

  • [By ]

    For an “Executive Decision” segment, Cramer spoke with Hamid Moghadam, chairman and CEO of the logistics REIT, Prologis Inc.  (PLD) , which recently announced the acquisition of DCT Industrial Trust (DCT) .

Top 5 Casino Stocks To Invest In 2019

Stars Group Inc.’s $4.7-billion purchase of Sky Betting & Gaming turns the online poker giant into a major sports-betting player that could use its strong foothold in Europe to cross the Atlantic if the U.S. market fully opens.

The Toronto-based operator of PokerStars, which announced the cash-and-stock deal with CVC Capital Partners and Sky Plc on Saturday, is set to win a significant foothold in the U.K. — the largest regulated gaming market. Sky Betting & Gaming, or SBG, is growing rapidly in online casino games and sports at home and recently expanded to Italy and Germany.

If an upcoming Supreme Court decision in the U.S. allows sports betting in more states, it would be the “icing on the cake” for the combined companies, according to Simon Holliday, founder of the research firm H2 Gambling Capital.

“The US sportsbetting Supreme Court case is obviously a big part of the potential upside, with Star’s old database, SBG’s strengths and their track record solely in the U.K.,” Holliday wrote in an email. “Even without the U.S., SBG is just starting to launch in other regulated markets.”

Top 5 Casino Stocks To Invest In 2019: Sify Technologies Limited(SIFY)

Advisors’ Opinion:

  • [By Lisa Levin]

    Friday afternoon, the telecommunication services shares rose 2.1 percent. Meanwhile, top gainers in the sector included Intelsat S.A. (NYSE: I), up 11 percent, and Sify Technologies Limited (NASDAQ: SIFY) up 4 percent.

  • [By Money Morning Reports]

    Like Sify Technologies Ltd. (Nasdaq: SIFY)… a 143% winner… Fanhua Inc. (Nasdaq: FANH)… a 245.56% winner… and Boot Barn Holdings Inc. (NYSE: BOOT)… netting an astounding gain of 260%.

Top 5 Casino Stocks To Invest In 2019: Fisher(j)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Joincoin (CURRENCY:J) traded 1.7% lower against the U.S. dollar during the 24 hour period ending at 0:00 AM ET on May 8th. Joincoin has a total market cap of $145,714.00 and $7.00 worth of Joincoin was traded on exchanges in the last 24 hours. During the last week, Joincoin has traded up 28.6% against the U.S. dollar. One Joincoin coin can currently be bought for about $0.0471 or 0.00000521 BTC on cryptocurrency exchanges.

  • [By Shane Hupp]

    Joincoin (J) is a proof-of-work (PoW) coin that uses the Multiple hashing algorithm. Its launch date was August 13th, 2014. Joincoin’s total supply is 3,173,702 coins. Joincoin’s official website is bitcointalk.org/index.php?topic=737405.0. Joincoin’s official Twitter account is @Joincoin_Team.

  • [By Logan Wallace]

    Joincoin (CURRENCY:J) traded 12.5% higher against the dollar during the 24-hour period ending at 10:00 AM ET on September 30th. Joincoin has a market cap of $98,508.00 and $17.00 worth of Joincoin was traded on exchanges in the last day. One Joincoin coin can now be bought for $0.0309 or 0.00000467 BTC on popular exchanges. During the last seven days, Joincoin has traded 8.2% lower against the dollar.

  • [By Logan Wallace]

    Joincoin (CURRENCY:J) traded 22.3% higher against the dollar during the 1 day period ending at 9:00 AM E.T. on October 2nd. Joincoin has a total market capitalization of $95,205.00 and $22.00 worth of Joincoin was traded on exchanges in the last 24 hours. During the last seven days, Joincoin has traded 6.1% lower against the dollar. One Joincoin coin can now be bought for approximately $0.0299 or 0.00000456 BTC on major cryptocurrency exchanges.

  • [By Shane Hupp]

    Joincoin (CURRENCY:J) traded 17.5% lower against the U.S. dollar during the twenty-four hour period ending at 17:00 PM ET on June 2nd. Over the last seven days, Joincoin has traded down 4.4% against the U.S. dollar. One Joincoin coin can now be purchased for $0.0862 or 0.00001129 BTC on major exchanges. Joincoin has a market capitalization of $267,889.00 and approximately $123.00 worth of Joincoin was traded on exchanges in the last 24 hours.

Top 5 Casino Stocks To Invest In 2019: Potlatch Corporation(PCH)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Potlatchdeltic (PCH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Shares of Potlatchdeltic Corp (NASDAQ:PCH) have received an average recommendation of “Hold” from the nine ratings firms that are currently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation and three have issued a buy recommendation on the company. The average twelve-month target price among analysts that have covered the stock in the last year is $49.60.

  • [By Joseph Griffin]

    PotlatchDeltic (NASDAQ:PCH) was upgraded by equities researchers at Vertical Research to a “hold” rating in a research report issued on Monday, The Fly reports. The analysts noted that the move was a valuation call.

  • [By Max Byerly]

    Shares of Potlatchdeltic Corp (NASDAQ:PCH) have received an average rating of “Hold” from the ten research firms that are covering the stock, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, four have issued a hold rating and four have issued a buy rating on the company. The average 1 year price target among brokers that have issued a report on the stock in the last year is $50.83.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Potlatchdeltic (PCH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Casino Stocks To Invest In 2019: Tile Shop Hldgs, Inc.(TTS)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Tile Shop Holdings, Inc. (NASDAQ: TTS) got a boost, shooting up 9 percent to $6.20 after the company posted upbeat quarterly earnings.

    Sientra, Inc. (NASDAQ: SIEN) shares were also up, gaining 9 percent to $12.03 following the announcement of FDA approval for PMA supplement.

  • [By Paul Ausick]

    Tile Shop Holdings Inc. (NASDAQ: TTS) dropped more than 31% Wednesday to post a new 52-week low of $5.80. Shares closed at $8.45 on Tuesday and the stock’s 52-week high is $22.40. Volume was around 6.3 million, about eight times the daily average of about 780,000. The company reported a quarterly loss this morning.

  • [By Ethan Ryder]

    Tile Shop Holdings Inc (NASDAQ:TTS) was the recipient of unusually large options trading on Monday. Stock investors purchased 964 put options on the company. This is an increase of 1,790% compared to the typical volume of 51 put options.

Top 5 Casino Stocks To Invest In 2019: ANSYS, Inc.(ANSS)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Ansys (NASDAQ:ANSS) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “ANSYS delivered strong results for first-quarter 2018, wherein both the top and bottom lines fared better than the respective Zacks Consensus Estimates. Increasing demand for simulation particularly from industries like energy bodes well for ANSYS. We believe that robust product portfolio, expanding total addressable market improving enterprise penetration, collaborations with leading vendors, and strong balance sheet are the catalysts. Acquisitions like 3DSIM and OPTIS are not only enabling ANSYS to bring innovative solutions to the market but are also aiding it to enhance foothold in the competitive simulations market. However, its margin is expected to remain under pressure as ANSYS continues to invest on product development. Furthermore, adverse foreign currency exchange rates are expected to impede revenue growth in the near term as it generates significant revenues from international market.”

  • [By Ethan Ryder]

    Commonwealth Bank of Australia lessened its holdings in shares of ANSYS, Inc. (NASDAQ:ANSS) by 0.2% during the second quarter, Holdings Channel reports. The institutional investor owned 462,175 shares of the software maker’s stock after selling 813 shares during the quarter. ANSYS accounts for approximately 0.8% of Commonwealth Bank of Australia’s portfolio, making the stock its 26th largest position. Commonwealth Bank of Australia’s holdings in ANSYS were worth $80,495,000 at the end of the most recent reporting period.

  • [By Logan Wallace]

    Ansys (NASDAQ:ANSS) Director James E. Cashman III sold 40,254 shares of the stock in a transaction on Tuesday, May 22nd. The shares were sold at an average price of $163.76, for a total value of $6,591,995.04. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

  • [By Ethan Ryder]

    ANSYS (NASDAQ:ANSS) was downgraded by equities researchers at BidaskClub from a “strong-buy” rating to a “buy” rating in a report released on Monday.

Top Warren Buffett Stocks To Watch Right Now

IN THE NEWS

After eking out a modest gain in the week ended April 27, the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB) pulled back this week amid some not-so-encouraging earnings reports and negative regulatory decisions: Link

Warren Buffett is still the face of Berkshire Hathaway Inc., (NYSE: BRK-A) but behind the scenes, his deputies are frequently calling the shots: Link $

Oil futures rose sharply in Asian trading Monday, hitting new 3 1/2-year highs as the U.S. benchmark hovered around $70 a barrel and a deadline to renew waivers of U.S. sanctions on Iran loomed: Link $

Talks to update the NAFTA trade deal enter a make-or-break week on Monday, as ministers from Canada, the United States and Mexico seek to resolve an impasse in key areas before elections in Mexico and the United States complicate the process: Link

Swiss-based food giant Nestle will pay Starbucks (NASDAQ: SBUX) $7.15 billion in cash for the rights to sell the U.S. coffee chain’s products around the world in a global alliance aimed at reinvigorating their coffee empires: Link

Not long after U.S. authorities filed sealed charges against Volkswagen’s (OTC: VLKAY) old chief executive officer, they granted the new CEO a rare safe-passage deal: Link

Top Warren Buffett Stocks To Watch Right Now: Intercontinental Hotels Group(IHG)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Playa Hotels & Resorts (NASDAQ: PLYA) and InterContinental Hotels Group (NYSE:IHG) are both consumer discretionary companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, dividends, risk, earnings, analyst recommendations, valuation and profitability.

  • [By Ethan Ryder]

    Liberum Capital reissued their hold rating on shares of InterContinental Hotels Group (LON:IHG) in a research report report published on Friday morning.

  • [By Max Byerly]

    Shares of InterContinental Hotels Group PLC (NYSE:IHG) have been given an average recommendation of “Hold” by the eight brokerages that are currently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and two have issued a buy rating on the company. The average twelve-month price objective among brokers that have covered the stock in the last year is $66.00.

Top Warren Buffett Stocks To Watch Right Now: AltaGas Ltd. (ATGFF)

Advisors’ Opinion:

  • [By ]

    AltaGas (OTCPK:ATGFF) agreed to acquire WGL (WGL) in January 2017, and the acquisition is still pending regulatory approval in DC, which is expected mid-2018. WGL operates Washington Gas, the gas utility in the region. The interesting play here I think is AltaGas. It offers a fairly well covered 8.5%+ dividend but has been beaten down as a result of concerns over the price paid for the WGL acquisition and the debt it will be required to take on in the deal. If the WGL acquisition does not receive regulatory approval, it’s very possible that AltaGas goes up. And if WGL is approved, it’s obviously a much better acquisition if Amazon picks anywhere in the DC area, as that should fuel a significant population increase for the gas utility business (some estimates of up to 1 million over 10 to 15 years). The projected growth in the gas utility business can serve as the foundation for AltaGas’s broader operations and allow them to finance debt at more attractive levels going forward. A mere re-rating to a market AFFO multiple would lead to substantial gains from the current 10-20% discount to market AFFO multiples, and a premium driven by the growth in Washington Gas could warrant a 10-20% premium to market AFFO multiples.

Top Warren Buffett Stocks To Watch Right Now: Education Realty Trust Inc.(EDR)

Advisors’ Opinion:

  • [By Lisa Levin]

    Tuesday afternoon, the real estate shares surged 0.32 percent. Meanwhile, top gainers in the sector included Pennsylvania Real Estate Investment Trust (NYSE: PEI), up 4 percent, and Education Realty Trust, Inc. (NYSE: EDR) up 3 percent.

  • [By Lisa Levin]

    On Wednesday, the real estate shares surged 0.87 percent. Meanwhile, top gainers in the sector included Innovative Industrial Properties, Inc. (NYSE: IIPR), up 3 percent, and Education Realty Trust, Inc. (NYSE: EDR) up 3 percent.

  • [By Joseph Griffin]

    Endeavour Silver Corp (TSE:EDR) (NYSE:EXK) insider Christine Deborah West sold 16,000 shares of the company’s stock in a transaction dated Monday, June 18th. The stock was sold at an average price of C$4.23, for a total value of C$67,680.00.

Top Warren Buffett Stocks To Watch Right Now: VistaGen Therapeutics, Inc. (VTGN)

Advisors’ Opinion:

  • [By Money Morning Staff Reports]

    For instance, VistaGen Therapeutics Inc. (Nasdaq: VTGN) shot up from $0.92 to $2.55 on Dec. 6. Since then, the stock pulled back to $1.19. Investors who bought at $2.55 are sitting on a 53.3% loss today (Feb. 20).

  • [By Logan Wallace]

    Maxim Group assumed coverage on shares of Vistagen Therapeutics (NASDAQ:VTGN). The firm issued a buy rating on the stock.

    Sanford C. Bernstein assumed coverage on shares of Zimmer Biomet (NYSE:ZBH). Sanford C. Bernstein issued an underperform rating on the stock.

  • [By Max Byerly]

    These are some of the media stories that may have effected Accern Sentiment Analysis’s scoring:

    Get Vistagen Therapeutics alerts:

    Investor’s Alert (Earnings Per Share) VistaGen Therapeutics Inc (NASDAQ: VTGN) (stocksmarketcap.com) Stock Technical’s & Performances to Explore VistaGen Therapeutics Inc (NASDAQ: VTGN) (stockspen.com) US STOCKS ON THE MOVE-Media and telecom stocks, H & R Block, TAL Education (nasdaq.com) Tracking the HMA Level on These Shares: VistaGen Therapeutics, Inc. (:VTGN): HMA Reading 1.4214792 (stocknewscaller.com) Keep Your Eyes on Hot Stock of Yesterday VistaGen Therapeutics, Inc. (VTGN) (stockmarketstop.com)

    Vistagen Therapeutics traded down $0.02, reaching $1.46, on Tuesday, according to MarketBeat Ratings. The company’s stock had a trading volume of 2,930 shares, compared to its average volume of 2,201,613. The stock has a market cap of $34.35 million, a P/E ratio of -0.95 and a beta of 0.29. Vistagen Therapeutics has a 52 week low of $0.69 and a 52 week high of $2.65.

Top Warren Buffett Stocks To Watch Right Now: Fisher(j)

Advisors’ Opinion:

  • [By Shane Hupp]

    Joincoin (CURRENCY:J) traded 17.5% lower against the U.S. dollar during the twenty-four hour period ending at 17:00 PM ET on June 2nd. Over the last seven days, Joincoin has traded down 4.4% against the U.S. dollar. One Joincoin coin can now be purchased for $0.0862 or 0.00001129 BTC on major exchanges. Joincoin has a market capitalization of $267,889.00 and approximately $123.00 worth of Joincoin was traded on exchanges in the last 24 hours.

  • [By Joseph Griffin]

    Joincoin (CURRENCY:J) traded 1.7% lower against the U.S. dollar during the 24 hour period ending at 0:00 AM ET on May 8th. Joincoin has a total market cap of $145,714.00 and $7.00 worth of Joincoin was traded on exchanges in the last 24 hours. During the last week, Joincoin has traded up 28.6% against the U.S. dollar. One Joincoin coin can currently be bought for about $0.0471 or 0.00000521 BTC on cryptocurrency exchanges.